Rights and permissions
About this article
Cite this article
Rituximab worth it in advanced-stage NHL?. Pharmacoecon. Outcomes News 471, 3–4 (2005). https://doi.org/10.2165/00151234-200504710-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504710-00004